share_log

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying

Assertio Holdings And 2 Other Penny Stocks Insiders Are Buying

Assertio Holdings和其他2只低價股票的內部人員正在購買
Benzinga ·  06/13 21:10

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週三收低約0.1%。當內部人士購買或賣出股票時，這表明他們對公司前景的信心或擔憂。對於有興趣投資或交易便士股的投資者和交易商而言，這是他們整體投資或交易決策中的一個因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是幾個近期關於低價股的值得關注的內部交易。了解更多，請查看Benzinga內幕交易平台。

Kronos Bio

kronos bio

  • The Trade: Kronos Bio, Inc. (NASDAQ:KRON) President and CEO Norbert W Bischofberger bought a total of 3,005,122 shares at an average price of $1.04. To acquire these shares, it cost around $3.12 million.
  • What's Happening: On May 21, Kronos Bio named Deborah Knobelman as COO and CFO.
  • What Kronos Bio Does: Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription.
  • 交易：納斯達克kronos bio股票代碼爲KRON的總裁兼CEO Norbert W Bischofberger以平均價1.04美元購買了305萬122股。花費大約312萬美元才能獲得這些股票。
  • 近況：5月21日，kronos bio任命Deborah Knobelman爲首席運營官和首席財務官。
  • kronos bio致力於發現和開發新型癌症治療方案，通過定向調節失調的轉錄來實現精準醫療計劃，以改變患者的治療效果。

Assertio Holdings

assertio

  • The Trade: Assertio Holdings, Inc. (NASDAQ:ASRT) Director Jeff L Vacirca acquired a total of 10,000 shares at an average price of $1.11. To acquire these shares, it cost around $11,100.
  • What's Happening: On June 6, Assertio Holdings reported inducement grants under NASDAQ Listing Rule 5635(c)(4).
  • What Assertio Holdings Does: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines.
  • 交易：納斯達克assertio holdings股票代碼爲ASRT的董事Jeff L Vacirca以平均價1.11美元購買了1萬股。花費約11100美元才能獲得這些股票。
  • 正在發生的事情：6月6日，Assertio Holdings根據納斯達克上市規則5635（c）（4）報告了引誘性授予。
  • Assertio Holdings Inc是一家藥品公司。它致力於在神經學、孤兒和特殊藥品領域提供解決方案，以推進患者護理。

Nanophase Technologies

Nanophase Technologies

  • The Trade: Nanophase Technologies Corporation (OTC:NANX) Director R Janet Whitmore acquired a total of 18,369 shares at an average price of $1.44. The insider spent around $26,487 to buy those shares.
  • What's Happening: On April 23, Nanophase Technologies announced financial results for the first quarter ended March 31, 2024.
  • What Nanophase Technologies Does: Nanophase Technologies Corp is engaged in the production of engineered nanomaterial solutions and larger, sub-micron, materials such as personal care sunscreens, architectural coatings, industrial coating applications, and abrasion-resistant additives, plastics additives, medical diagnostics, energy.
  • 交易：場外交易股票代碼爲NANX的Nanophase Technologies Corporation的董事R Janet Whitmore以平均價1.44美元購買了18369股，總花費約爲26487美元。
  • 近況：4月23日，Nanophase Technologies宣佈了2024年3月31日結束的第一季度的財務業績。
  • Nanophase Technologies Corp專注於生產工程納米材料解決方案和更大型的次微米材料，例如個人護理防曬霜、建築塗料、工業塗料應用、耐磨添加劑、塑料添加劑、醫療診斷和能源等。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論